211 related articles for article (PubMed ID: 11119606)
41. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
42. Sequence elements of the adeno-associated virus rep gene required for suppression of herpes-simplex-virus-induced DNA amplification.
Kleinschmidt JA; Möhler M; Weindler FW; Heilbronn R
Virology; 1995 Jan; 206(1):254-62. PubMed ID: 7831779
[TBL] [Abstract][Full Text] [Related]
43. Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats.
Wang XS; Qing K; Ponnazhagan S; Srivastava A
J Virol; 1997 Apr; 71(4):3077-82. PubMed ID: 9060669
[TBL] [Abstract][Full Text] [Related]
44. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses.
Qiu J; Nayak R; Tullis GE; Pintel DJ
J Virol; 2002 Dec; 76(24):12435-47. PubMed ID: 12438569
[TBL] [Abstract][Full Text] [Related]
46. Identification of mutant adeno-associated virus Rep proteins which are dominant-negative for DNA helicase activity.
Kyöstiö SR; Owens RA
Biochem Biophys Res Commun; 1996 Mar; 220(2):294-9. PubMed ID: 8645299
[TBL] [Abstract][Full Text] [Related]
47. Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein.
Rinaudo D; Lamartina S; Roscilli G; Ciliberto G; Toniatti C
J Virol; 2000 Jan; 74(1):281-94. PubMed ID: 10590116
[TBL] [Abstract][Full Text] [Related]
48. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
49. Cloning and characterization of a bovine adeno-associated virus.
Schmidt M; Katano H; Bossis I; Chiorini JA
J Virol; 2004 Jun; 78(12):6509-16. PubMed ID: 15163744
[TBL] [Abstract][Full Text] [Related]
50. Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide.
Mendelson E; Trempe JP; Carter BJ
J Virol; 1986 Dec; 60(3):823-32. PubMed ID: 3023672
[TBL] [Abstract][Full Text] [Related]
51. Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.
Srivastava CH; Samulski RJ; Lu L; Larsen SH; Srivastava A
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8078-82. PubMed ID: 2554300
[TBL] [Abstract][Full Text] [Related]
52. Effects of adeno-associated virus on adenovirus replication and gene expression during coinfection.
Timpe JM; Verrill KC; Trempe JP
J Virol; 2006 Aug; 80(16):7807-15. PubMed ID: 16873238
[TBL] [Abstract][Full Text] [Related]
53. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines.
Toublanc E; Benraiss A; Bonnin D; Blouin V; Brument N; Cartier N; Epstein AL; Moullier P; Salvetti A
J Gene Med; 2004 May; 6(5):555-64. PubMed ID: 15133766
[TBL] [Abstract][Full Text] [Related]
54. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography.
Tamayose K; Hirai Y; Shimada T
Hum Gene Ther; 1996 Mar; 7(4):507-13. PubMed ID: 8800745
[TBL] [Abstract][Full Text] [Related]
55. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.
Smith RH; Afione SA; Kotin RM
Biotechniques; 2002 Jul; 33(1):204-6, 208, 210-1. PubMed ID: 12139247
[TBL] [Abstract][Full Text] [Related]
56. Transgene expression after rep-mediated site-specific integration into chromosome 19.
Philpott NJ; Gomos J; Falck-Pedersen E
Hum Gene Ther; 2004 Jan; 15(1):47-61. PubMed ID: 14965377
[TBL] [Abstract][Full Text] [Related]
57. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
Whiteway A; Deru W; Prentice HG; Anderson R
J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
[TBL] [Abstract][Full Text] [Related]
58. Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production.
Bowles DE; Rabinowitz JE; Samulski RJ
J Virol; 2003 Jan; 77(1):423-32. PubMed ID: 12477847
[TBL] [Abstract][Full Text] [Related]
59. Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers.
Weitzman MD; Fisher KJ; Wilson JM
J Virol; 1996 Mar; 70(3):1845-54. PubMed ID: 8627709
[TBL] [Abstract][Full Text] [Related]
60. Structural and functional heterogeneity of integrated recombinant AAV genomes.
Duan D; Fisher KJ; Burda JF; Engelhardt JF
Virus Res; 1997 Apr; 48(1):41-56. PubMed ID: 9140193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
